Cited by 841Amyotrophic Lateral Sclerosis ResearchGenetic Neurodegenerative DiseasesHereditary Neurological Disorders

GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport

Open access
Freibaum, Brian D., Lu, Yubing, Lopez-Gonzalez, Rodrigo, Kim, Nam Chul, Almeida, Sandra, Lee, Kyung-Ha, Badders, Nisha, Valentine, Marc +6 more·2015·Nature

Abstract

The GGGGCC (G4C2) repeat expansion in a noncoding region of C9orf72 is the most common cause of sporadic and familial forms of amyotrophic lateral sclerosis and frontotemporal dementia. The basis for pathogenesis is unknown. To elucidate the consequences of G4C2 repeat expansion in a tractable genetic system, we generated transgenic fly lines expressing 8, 28 or 58 G4C2-repeat-containing transcripts that do not have a translation start site (AUG) but contain an open-reading frame for green fluorescent protein to detect repeat-associated non-AUG (RAN) translation. We show that these transgenic animals display dosage-dependent, repeat-length-dependent degeneration in neuronal tissues and RAN translation of dipeptide repeat (DPR) proteins, as observed in patients with C9orf72-related disease. This model was used in a large-scale, unbiased genetic screen, ultimately leading to the identification of 18 genetic modifiers that encode components of the nuclear pore complex (NPC), as well as the machinery that coordinates the export of nuclear RNA and the import of nuclear proteins. Consistent with these results, we found morphological abnormalities in the architecture of the nuclear envelope in cells expressing expanded G4C2 repeats in vitro and in vivo. Moreover, we identified a substantial defect in RNA export resulting in retention of RNA in the nuclei of Drosophila cells expressing expanded G4C2 repeats and also in mammalian cells, including aged induced pluripotent stem-cell-derived neurons from patients with C9orf72-related disease. These studies show that a primary consequence of G4C2 repeat expansion is the compromise of nucleocytoplasmic transport through the nuclear pore, revealing a novel mechanism of neurodegeneration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nature14974

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Genetic screens in ALS model systems have repeatedly uncovered nuclear pore and nucleocytoplasmic transport factors as potent disease modifiers.

    “Genetic screens in ALS model systems have repeatedly uncovered nuclear pore and nucleocytoplasmic transport factors as potent disease modifiers, confirming the significance of these pathways in disease pathogenesis (9–11).”

    From Nemo-like kinase disrupts nuclear import and drives TDP43 mislocalization in ALS (2025) · cites this paper as [11]

    The paper’s study description reports one genetic screen in a C9ORF72 ALS/FTD fly model that identified nuclear pore and nucleocytoplasmic transport genes as modifiers. It also identifies strong suppressors and links transport defects to degeneration. This source supports an instance of the finding, but does not itself establish that genetic screens have repeatedly found it. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Disruption of the Ran gradient, mislocalization of nuclear pore components, and disturbance of nuclear pore architecture have likewise been described in ALS/FTLD-TDP samples and disease models.

    “Disruption of the Ran gradient, mislocalization of nuclear pore components, and disturbance of nuclear pore architecture — all of which we observed upon NLK overexpression — have likewise been described in ALS/FTLD-TDP samples and disease models (9–11, 50).”

    From Nemo-like kinase disrupts nuclear import and drives TDP43 mislocalization in ALS (2025) · cites this paper as [11]

    The paper’s results (Fig. 3a–c; page unavailable in our copy) describe mislocalized Nup107 and abnormal nuclear-envelope architecture in a C9ORF72 repeat-expansion fly model. Its patient-derived neurons show altered RNA distribution, but the copy does not describe a disrupted Ran gradient or establish these structural findings across ALS/FTLD-TDP samples generally. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 30

  1. [4]Xu Z Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration Proc Natl Acad Sci U S A 110 7778 7783 10.1073/pnas.1219643110 2013 23553836 PMC3651485 · DOI
  2. [5]Kwon I Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells Science 345 1139 1145 10.1126/science.1254917 2014 25081482 PMC4459787 · DOI
  3. [6]Wen X Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death Neuron 84 1213 1225 10.1016/j.neuron.2014.12.010 2014 25521377 PMC4632245 · DOI
  4. [7]Makise M The Nup153-Nup50 protein interface and its role in nuclear import J Biol Chem 287 38515 38522 10.1074/jbc.M112.378893 2012 23007389 PMC3493896 · DOI
  5. [8]Cesario J McKim KS RanGTP is required for meiotic spindle organization and the initiation of embryonic development in Drosophila J Cell Sci 124 3797 3810 10.1242/jcs.084855 2011 22100918 PMC3225268 · DOI
  6. [9]Reed R Coupling transcription, splicing and mRNA export Curr Opin Cell Biol 15 326 331 2003 12787775
  7. [10]Viphakone N TREX exposes the RNA-binding domain of Nxf1 to enable mRNA export Nat Commun 3 1006 10.1038/ncomms2005 2012 22893130 PMC3654228 · DOI
  8. [11]Zhou Z The protein Aly links pre-messenger-RNA splicing to nuclear export in metazoans Nature 407 401 405 10.1038/35030160 2000 11014198 · DOI
  9. [12]Chang CT Chtop is a component of the dynamic TREX mRNA export complex The EMBO journal 32 473 486 10.1038/emboj.2012.342 2013 23299939 PMC3567497 · DOI
  10. [13]Wan J Mutations in the RNA exosome component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degeneration Nat Genet 44 704 708 10.1038/ng.2254 2012 22544365 PMC3366034 · DOI · Paper page
  11. [14]Cheng H Human mRNA export machinery recruited to the 5 end of mRNA Cell 127 1389 1400 10.1016/j.cell.2006.10.044 2006 17190602 · DOI
  12. [15]Boehmer T Enninga J Dales S Blobel G Zhong H Depletion of a single nucleoporin, Nup107, prevents the assembly of a subset of nucleoporins into the nuclear pore complex Proc Natl Acad Sci U S A 100 981 985 10.1073/pnas.252749899 2003 12552102 PMC298712 · DOI
  13. [16]Vasu S Novel vertebrate nucleoporins Nup133 and Nup160 play a role in mRNA export J Cell Biol 155 339 354 10.1083/jcb.200108007 2001 11684705 PMC2150853 · DOI
  14. [17]Walther TC The conserved Nup107-160 complex is critical for nuclear pore complex assembly Cell 113 195 206 2003 12705868
  15. [18]Murphy R Wente SR An RNA-export mediator with an essential nuclear export signal Nature 383 357 360 10.1038/383357a0 1996 8848052 · DOI
  16. [19]Nousiainen HO Mutations in mRNA export mediator GLE1 result in a fetal motoneuron disease Nat Genet 40 155 157 10.1038/ng.2007.65 2008 18204449 PMC2684619 · DOI
  17. [20]Kaneb HM Deleterious mutations in the essential mRNA metabolism factor, hGle1, in amyotrophic lateral sclerosis Hum Mol Genet 24 1363 1373 10.1093/hmg/ddu545 2015 25343993 PMC4321443 · DOI
  18. [22]van Blitterswijk M DeJesus-Hernandez M Rademakers R How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders? Curr Opin Neurol 25 689 700 10.1097/WCO.0b013e32835a3efb 2012 23160421 PMC3923493 · DOI
  19. [24]Zhang Z Downregulation of microRNA-9 in iPSC-derived neurons of FTD/ALS patients with TDP-43 mutations PLoS One 8 e76055 10.1371/journal.pone.0076055 2013 24143176 PMC3797144 · DOI · Paper page
  20. [25]Sareen D Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion Sci Transl Med 5 208ra149 10.1126/scitranslmed.3007529 2013 PMC4090945 24154603 · DOI · Paper page
  21. [26]Cronshaw JM Matunis MJ The nuclear pore complex: disease associations and functional correlations Trends Endocrinol Metab 15 34 39 2004 14693424
  22. [28]Mor A White MA Fontoura BM Nuclear trafficking in health and disease Curr Opin Cell Biol 28 28 35 10.1016/j.ceb.2014.01.007 2014 24530809 PMC4061247 · DOI
  23. [29]Bonnet A Palancade B Regulation of mRNA trafficking by nuclear pore complexes Genes (Basel) 5 767 791 10.3390/genes5030767 2014 25184662 PMC4198930 · DOI
  24. [30]Zhang YJ Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress Acta Neuropathol 128 505 524 10.1007/s00401-014-1336-5 2014 25173361 PMC4159567 · DOI
  25. [31]Kim NC VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations Neuron 78 65 80 10.1016/j.neuron.2013.02.029 2013 23498974 PMC3683300 · DOI
  26. [32]Smith R Taylor JP Dissection and imaging of active zones in the Drosophila neuromuscular junction Journal of visualized experiments: JoVE 10.3791/2676 2011 PMC3169289 21559003 · DOI
  27. [33]Gendron TF Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS Acta neuropathologica 126 829 844 10.1007/s00401-013-1192-8 2013 24129584 PMC3830741 · DOI
  28. [34]Ash PE Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS Neuron 77 639 646 10.1016/j.neuron.2013.02.004 2013 23415312 PMC3593233 · DOI
  29. [35]Almeida S Induced pluripotent stem cell models of deficient frontotemporal dementia uncover specific reversible neuronal defects Cell Rep 2 789 798 10.1016/j.celrep.2012.09.007 2012 23063362 PMC3532907 · DOI · Paper page
  30. [36]Okita K A more efficient method to generate integration-free human iPS cells Nat Methods 8 409 412 10.1038/nmeth.1591 2011 21460823 · DOI · Paper page

Cited by

Sorted by citations

Authors
Freibaum, B. D., Lu, Y., Lopez-Gonzalez, R., Kim, N. C., Almeida, S., Lee, K.-H., Badders, N., Valentine, M., Miller, B. L., Wong, P. C., Petrucelli, L., Kim, H. J., Gao, F.-B., & Taylor, J. P.
Affiliations
  • St. Jude Children's Research Hospital (US)
  • University of Massachusetts Chan Medical School (US)
  • University of California, San Francisco (US)
  • Johns Hopkins University (US)
  • Mayo Clinic in Florida (US)
Corresponding author
  • Gao, Fen-Biao
  • Taylor, J. Paul
Venue
Nature
Published
2015-08-26
Volume
525
Issue
7567
Pages
129-133
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W1796096082
Cited by
841
References
6
Citations by year
2026: 35 · 2025: 48 · 2024: 61 · 2023: 57 · 2022: 62 · 2021: 102 · 2020: 96 · 2019: 83 · 2018: 95 · 2017: 91 · 2016: 90 · 2015: 21
FWCI
69.80
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • Howard Hughes Medical Institute
  • U.S. Public Health Service (N079725)
  • National Institute on Aging (P50AG005146, AG019724, P01AG019724)
  • National Cancer Institute (P30CA021765)
  • National Institute of Neurological Disorders and Stroke (NS079725, R01NS057553, R01NS079725)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Keywords
C9orf72, G4C2 repeat expansion, nuclear transport, amyotrophic lateral sclerosis, frontotemporal dementia, RanGAP, nuclear pores, dipeptide repeat proteins, repeat-associated non-AUG translation, G-quadruplex, antisense oligonucleotides, small molecules, neurodegeneration
MeSH terms
C9orf72 Protein, Amyotrophic Lateral Sclerosis, Animals, Drosophila melanogaster, Eye, Female, HeLa Cells, Humans, Male, Muscles, Neurons, Phenotype, Proteins, RNA, Salivary Glands, Protein Biosynthesis, Open Reading Frames, Active Transport, Cell Nucleus, Nuclear Pore, Animals, Genetically Modified, RNA Transport, DNA Repeat Expansion, Induced Pluripotent Stem Cells, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review